Navigation Links
Pharmaceutical Benefits Scheme Extended for 2 Novel Breast Cancer Drugs

Two new drugs to battle breast cancer have made their way into the Pharmaceutical Benefits Scheme which is a succor for the multitude of sufferers//, who can now avail superior treatment notwithstanding the cost of drugs. This is good news as breast cancer carries the ignominy of being the most common cancer befalling women, affecting 14,000 people annually.

The drugs are targeted at post-menopausal women suffering hormone-dependant early breast cancer, who will be in a position to avail the drug from December 1.

Breast Cancer Network Australia CEO Lyn Swinburne explained that the drugs, called as aromatase inhibitors, were consumed by more than 50% of women suffering breast cancer. Ms Swinburne said "It is important these drugs are on the PBS because they offer women choice. Women shouldn't have to worry about the cost; they have enough decisions to make and options to consider without the added worry of how they are going to pay for these things. What we want is the best treatment for the individual woman to ensure she has the best chance of recovery."

National Breast Cancer Centre acting deputy director Dr Alison Evans said, "Their listing on the PBS is wonderful news as it provides additional treatment options for patients with early breast cancer."


'"/>




Page: 1

Related medicine news :

1. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
2. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
3. Medicis Pharmaceutical company enters pediatric market
4. Pharmaceutical companies are targeting patients
5. FDA approves Watson Pharmaceuticals Oxytrol patch
6. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
7. Indian Pharmaceutical Industries Stops Manufacturing And Sale Of Valdecoxib
8. Pharmaceutical industries grant for R&D to be monitored
9. Japanese And Chinese Pharmaceutical Companies Join Together In Drug Testing
10. Antigenics Pharmaceuticals plans for Phase III trial of its Melanoma vaccine
11. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/21/2017)... ... July 21, 2017 , ... The Margarian Law Firm has ... contents of its ginger ale for allegedly containing no ginger. Dr. Pepper produces the ... Group, Inc., plaintiff Gegham Margaryan alleges Canada Dry Ginger Ale claims on its bottle ...
(Date:7/21/2017)... ... July 21, 2017 , ... ... students improve their chances of acceptance to a residency in a United States ... earned degrees outside the U.S. , According to data released by the ECFMG®, ...
(Date:7/21/2017)... ... 21, 2017 , ... West Dermatology is pleased to announce the newest addition ... 2017, Ms. Vu will join West Dermatology’s large network of medical and cosmetic dermatology ... cancer , and more. She graduated from the University of Florida College of Medicine ...
(Date:7/21/2017)... , ... July 21, 2017 , ... ... why concussion rates are on the rise, say researchers presenting their work at ... Toronto, Ontario, Canada. , “The combination of evaluating the patterns of change in ...
(Date:7/20/2017)... ... July 20, 2017 , ... ... bone marrow cancer that progresses rapidly without treatment. Newly diagnosed patients face intense ... chance of reoccurrence and relapse. With such a challenging diagnosis that requires ...
Breaking Medicine News(10 mins):
(Date:7/5/2017)... MINNEAPOLIS , July 5, 2017 Pace Analytical, a company of ... announcing today that they have acquired ESC Lab Sciences, further solidifying their position ... the United States . ... Steve Vanderboom- President and CEO of Pace Analytical ... of ESC Lab Sciences out of Mt Juliet, TN , ...
(Date:7/1/2017)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today ... be broadcast live over the Internet on Thursday, July 27, ... the quarterly results will be made available at 7:30 a.m. ... The live audio webcast can be accessed via Zimmer Biomet,s ... archived for replay following the conference call. ...
(Date:6/30/2017)... Medical (AVACEN) announced the publication of new research in the peer-reviewed ... AVACEN Treatment Method to significantly reduce the widespread pain ... ... ... 200 to 400 million people worldwide according to The National Fibromyalgia ...
Breaking Medicine Technology: